New Patent Granted

Cerebriu has i May 2019 been granted US Patent No. 15/511770 regarding MRI dual differential bias correction.
Which is an essential technology for measuring small differences occurring over time in diseases like dementia, cancer, multiple sclerosis etc.

The patent granted ( includes an essential technology for measuring development over time between two MRIs recorded with some time in between. MRIs are confounded by a bias field that varies from recording to recording. These are normally removed by image analysis technology prior to quantitatively analysing images. However, when removed independently from two images, they are removed in slightly different ways given rise to substantial error in most quantitive measurements. The Cerebriu patent protects technology on how to remove the bias field in both images in the same way to minimise the error in measurement of different.